These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17105415)

  • 21. [The utility of metalloproteinases (MMPs) and their inhibitors (TIMPs) in diagnostics of gynecological malignancies].
    Mieszało K; Ławicki S; Szmitkowski M
    Pol Merkur Lekarski; 2016 Mar; 40(237):193-7. PubMed ID: 27088204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered matrix metalloproteinases and tissue inhibitors of metalloproteinases in embryos from diabetic rats during early organogenesis.
    Higa R; Kurtz M; Capobianco E; Martínez N; White V; Jawerbaum A
    Reprod Toxicol; 2011 Dec; 32(4):449-62. PubMed ID: 21963884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interplay of angiotensin II and angiotensin(1-7) in the regulation of matrix metalloproteinases of human cardiocytes.
    Pan CH; Wen CH; Lin CS
    Exp Physiol; 2008 May; 93(5):599-612. PubMed ID: 18296491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and characterization of 111In-DTPA-N-TIMP-2: a radiopharmaceutical for imaging matrix metalloproteinase expression.
    Giersing BK; Rae MT; CarballidoBrea M; Williamson RA; Blower PJ
    Bioconjug Chem; 2001; 12(6):964-71. PubMed ID: 11716687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The distribution of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the lungs of congenital diaphragmatic hernia patients and age-matched controls.
    Masumoto K; de Rooij JD; Suita S; Rottier R; Tibboel D; de Krijger RR
    Histopathology; 2006 Apr; 48(5):588-95. PubMed ID: 16623785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. mRNA expression profile of matrix metalloproteinases and their tissue inhibitors in malignant and non-malignant prostatic tissue.
    Lichtinghagen R; Musholt PB; Stephan C; Lein M; Kristiansen G; Hauptmann S; Rudolph B; Schnorr D; Loening SA; Jung K
    Anticancer Res; 2003; 23(3B):2617-24. PubMed ID: 12894549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves.
    Dreger SA; Taylor PM; Allen SP; Yacoub MH
    J Heart Valve Dis; 2002 Nov; 11(6):875-80; discussion 880. PubMed ID: 12479292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder.
    Hara I; Miyake H; Hara S; Arakawa S; Kamidono S
    J Urol; 2001 May; 165(5):1769-72. PubMed ID: 11342973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrix metalloproteinases and their tissue inhibitors in the lesions of cardiac and pulmonary sarcoidosis: an immunohistochemical study.
    González AA; Segura AM; Horiba K; Qian S; Yu ZX; Stetler-Stevenson W; Willerson JT; McAllister HA; Ferrans VJ
    Hum Pathol; 2002 Dec; 33(12):1158-64. PubMed ID: 12514782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of matrix metalloproteinases-9, 2 and their inhibitor-TIMP-1, 2 in invasive pituitary adenomas biological behavior].
    He DS; Chen MZ; Wang HJ; Ke CL; Yan C; Zheng H; Hong YS
    Ai Zheng; 2002 Oct; 21(10):1124-8. PubMed ID: 12508658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of fibroblast growth factor-2 in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human intestinal myofibroblasts.
    Yasui H; Andoh A; Bamba S; Inatomi O; Ishida H; Fujiyama Y
    Digestion; 2004; 69(1):34-44. PubMed ID: 14755151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
    Matsunaga Y; Koda M; Murawaki Y
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of epidermal growth factor on matrix metalloproteinases and tissue inhibitors of metalloproteinase gene expression in cultured human gingival fibroblasts.
    Cury PR; de Araújo VC; Canavez F; Furuse C; Leite KR; de Araújo NS
    Arch Oral Biol; 2007 Jun; 52(6):585-90. PubMed ID: 17181997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases during normal human pulmonary development.
    Masumoto K; de Rooij JD; Suita S; Rottier R; Tibboel D; de Krijger RR
    Histopathology; 2005 Oct; 47(4):410-9. PubMed ID: 16178896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physical exercise can influence local levels of matrix metalloproteinases and their inhibitors in tendon-related connective tissue.
    Koskinen SO; Heinemeier KM; Olesen JL; Langberg H; Kjaer M
    J Appl Physiol (1985); 2004 Mar; 96(3):861-4. PubMed ID: 14506093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for a role of matrix metalloproteinases and their inhibitors in primordial germ cell migration.
    Díez-Torre A; Díaz-Núñez M; Eguizábal C; Silván U; Aréchaga J
    Andrology; 2013 Sep; 1(5):779-86. PubMed ID: 23843195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of irregular bleeding with hormone therapy: the role of matrix metalloproteinases and their tissue inhibitors.
    Hickey M; Crewe J; Mahoney LA; Doherty DA; Fraser IS; Salamonsen LA
    J Clin Endocrinol Metab; 2006 Aug; 91(8):3189-98. PubMed ID: 16684831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
    Misugi F; Sumi T; Okamoto E; Nobeyama H; Hattori K; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
    Int J Mol Med; 2005 Oct; 16(4):541-6. PubMed ID: 16142384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostate cancer cell lines.
    Daja MM; Niu X; Zhao Z; Brown JM; Russell PJ
    Prostate Cancer Prostatic Dis; 2003; 6(1):15-26. PubMed ID: 12664060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging.
    Breyholz HJ; Schäfers M; Wagner S; Höltke C; Faust A; Rabeneck H; Levkau B; Schober O; Kopka K
    J Med Chem; 2005 May; 48(9):3400-9. PubMed ID: 15857146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.